|
|
Avantor Inc 's Yearly Free Cash Flow Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
AVTR Annual Free Cash Flow Growth |
2023
|
2022
|
2020
|
2019
|
|
Y / Y Annual Free Cash Flow Change |
1.89 % |
-18.2 % |
187.1 % |
- |
- |
Annual Free Cash Flow (in millions $) |
$723.60 |
$710.20 |
$868.20 |
$302.40 |
$0.00 |
Annual Free Cash Flow Growth
Comment |
Avantor Inc 's Annual Free Cash Flow for the fiscal year ended 2023, increased by 1.89% to $723.60 millions, from $710.20 millions achieved a year ago. Avantor Inc 's growrh rate for Free Cash Flow improved from -18.2 % decline in the fiscal year 2022.
Avantor Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Free Cash Flow within Healthcare Sector | Y/Y Free Cash Flow Growth % | 2023 Annual Free Cash Flow | Pfizer Inc | -81.59 % | $ 4,793.000 millions | Biontech Se | -61.34 % | $ 5,736.640 millions | Abbott Laboratories | -35.17 % | $ 5,059.000 millions | Medtronic Plc | -23.39 % | $ 4,580.000 millions | Eli Lilly And Company | -54.17 % | $ 2,396.800 millions | Regeneron Pharmaceuticals Inc | -12.42 % | $ 3,875.400 millions | 3m Company | 28.25 % | $ 5,184.000 millions | Vertex Pharmaceuticals Inc | -16.47 % | $ 3,278.900 millions | Viatris Inc | -4.84 % | $ 2,436.600 millions | Fresenius Medical Care Ag | 20.03 % | $ 2,962.332 millions | Royalty Pharma Plc | 39.36 % | $ 2,987.802 millions | Stryker Corp | 54.03 % | $ 3,136.000 millions | Iqvia Holdings Inc | -5.42 % | $ 1,500.000 millions | Becton Dickinson And Company | 41.26 % | $ 2,116.000 millions | Zoetis Inc | 22.46 % | $ 1,625.000 millions | Agilent Technologies inc | 12.35 % | $ 1,474.000 millions | Davita Inc | 55.13 % | $ 1,491.046 millions | Dr Reddy s Laboratories Limited | 119.38 % | $ 1,426.000 millions | Henry Schein Inc | -30.24 % | $ 353.000 millions | The Cooper Companies Inc | -52.26 % | $ 215.000 millions | Arcus Biosciences Inc | | | |